Katherine J. Selzler

Trial of Solanezumab for Mild Dementia Due to Alzheimer’s Disease

Lawrence S. Honig, Bruno Vellas, Merçé Boada et al. · New England Journal of Medicine · 2018 · 1K citations · Full text

Medicine, Neurology, Pharmacology +17

Galcanezumab in chronic migraine

Holland C. Detke, Peter J. Goadsby, Shufang Wang et al. · Neurology · 2018 · 578 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +15

Efficacy and Safety of Lanabecestat for Treatment of Early and Mild Alzheimer Disease

Alette M. Wessels, Pierre N. Tariot, Jennifer A. Zimmer et al. · JAMA Neurology · 2019 · 203 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

A phase 3, long-term, open-label safety study of Galcanezumab in patients with migraine

Angelo Camporeale, David Kudrow, Ryan Sides et al. · BMC Neurology · 2018 · 141 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Cognitive and Functional Decline and Their Relationship in Patients with Mild Alzheimer's Dementia

Hong Liu‐Seifert, Eric Siemers, Karen Sundell et al. · Journal of Alzheimer s Disease · 2014 · 82 citations

Medicine, Geriatric Medicine, Neurology +17